MedTrace Logo

YAZ Post-marketing Surveillance in Japan

NCT01375998 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3273

Last updated 2019-03-07

No results posted yet for this study

Summary

This study is a regulatory post marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received YAZ for dysmenorrhea. The objective of this study is to assess safety and efficacy of using YAZ in clinical practice. A total 3,000 patients will be recruited and followed 3 years since starting YAZ administration.

Conditions

  • Dysmenorrhea

Interventions

DRUG

EE20/DRSP(YAZ, BAY86-5300)

Patients in daily life treatment receiving YAZ for dysmenorrhea.

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-09
Primary Completion
2017-12-05
Completion
2018-03-08

Countries

  • Japan

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01375998 on ClinicalTrials.gov